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ABSTRACT

Recent advances in Generative Adversarial Networks (GANs) have led to many new uses of GANs. The latest advancements
have allowed researchers and practitioners to apply this them to tumor-related problems with limited data. This research
investigated literature on GANs and their uses in tumor-related research. The literature surveyed utilized academic databases
over the course of June 2014 and February 2021. This paper aims to develop a research agenda for information systems through
a systematic literature review that investigates practitioners' and researchers' emerging issues and current works on the topic.
Emerging implementation trends and limitations of GANs in tumor-related problems are also explored. The findings showed
that there is a significant gap between GAN development and implementation and that there are many areas where researchers
and practitioners can contribute to further the research and application of GANs.
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INTRODUCTION

Generative Adversarial Networks (GANs) were proposed by Goodfellow et al. in 2014 (Goodfellow et al., 2014). GANs
provide a way to learn deep representations without extensively annotated training data (Creswell et al., 2018). Their application
and ability to synthesize and augment data stimulated their use within the medical imaging domain. GANs were considered a
popular semi-supervised and unsupervised machine learning approach for medical image analysis. There are different
architectures of GANs which are used as alternative approaches to problems. The various architectures are fully connected,
convolutional, conditional, inference models, and adversarial autoencoders (Creswell et al., 2018).
A gap between the development of GANs and their implementation currently exists in tumor-related research. Practitioners are
concerned with current challenges in their particular work settings, while academics develop more generalizable rules and
understanding (Belanger et al., 2002). Academics focus more on understanding a rigorous comparison between different GANs
and practitioners focus on developing high-performing GANs that solve problems. GANs are gaining popularity, therefore it
is important to understand the gap between development and implementation and set forth an agenda for the information
systems discipline.
Therefore, two objectives are posited in this paper:
1.
2.

To examine the gap between GAN development and implementation in tumor-related research; and
To identify a research agenda to address emerging issues and concerns relevant to the information systems discipline.

This study proceeds by examining the gap between GAN development and variant implementation through a systematic
literature review. First, we define a specific methodology. Following that, a brief literature review is completed to summarize
the current state of the literature and identify gaps. The results are presented and discussed. A brief research agenda is proposed
in the discussion and identifies research gaps. The article will conclude with reflections on the findings following the agenda.
The main contribution of this paper is to examine the development and implementation gap of GANs and propose an
information systems research agenda for moving forward.
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METHODOLOGY
Overview

This review followed the PRISMA guidelines (Liberati et al., 2009).
The PRISMA chart is shown in Figure 1. Eligible articles were
searched for in MEDLINE, IEEE, ScienceDirect, BSP, ACM, and
ASP. The papers collected were from June 2014 and February 2021.
The search strategy for each database was completed using the
keywords "generative adversarial network" and "tumor." Original
research studies were included that used GANs for tumor-related
research.
The excluded studies did not match the keyword in the title or
abstract. Since GANs were developed in 2014, studies before then
were excluded. Inclusion eligibility was assessed individually by
evaluating the title and abstract of the article for the keywords
suggested above in the search strategy. The included studies that met
the search strategy were classified through Table 1. The same
researcher evaluated and classified the full text of the included
articles.

Figure 1. PRISMA chart

The following features were extracted and classified from each of the included studies to answer each of the research questions
posited in Table 1. The studies that met the
Table 1. Question and attribute table
inclusion criteria were summarized based on
attributes laid out in
Research Question
Category
Feature
Description
Table 1.
LITERATURE
REVIEW

(1) What GANs are being used for tumorrelated tasks?

Problem

Medical task

Medical task performed

Anatomical site

Organ or body area

Previous literature (2) What modalities are being used most Input
Image type
Modality used in the study
in the field focuses frequently with the application of GANs
Dataset used
Data type and name
on the broader topic and their variants?
of GANs in medical (3) Which GAN architectures are used and Process
GAN variant
Type of GAN
imaging
and what are the most prevalent?
creating
artificial
Visualization
Technique used for interpretation
images for radiology (4) What visualization method was used Output
for
interpretation?
of the GAN
applications using
GANs (Sorin et al.,
2020; Yi et al., 2019). Another paper investigates a similar issue from a different perspective by looking into general deep
learning models applied to electronic health records (Xiao et al., 2018). Previous papers have not investigated which variants
are being used to solve specific tumor-related problems. In (Aggarwal et al., 2021), the authors discuss the current state of
GANs in their paper and detail an increase in articles written from 378 in 2019 to 1392 in 2020. While there is an increase in
articles, there are no distinct review articles that investigate specific applications and visualization of GANs or their variants
and how they are used to solve that problem in the tumor problem domain.
GANs and their extensions have carved open many exciting ways to tackle well-known and challenging medical image analysis
problems such as medical image de-noising, reconstruction, segmentation, data simulation, detection or classification
(Kazeminia et al., 2020). The improvements being made in this study area are due to: (1) GANs maximizing the probability
density over the data generating distribution by exploiting density ratio estimation (Isola et al., 2017) in an indirect fashion of
supervision; and (2) GANs can discover the high dimensional latent distribution of data, which has led to significant
performance gains in the extraction of visual features (Kazeminia et al., 2020). These improvements are helpful, but significant
research must be completed further to understand the implementation and utility of their variants.
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RESULTS

The search resulted in 248 studies. Fifty-nine duplicate
records were removed. The screening stage involved a
title and abstract review of the remaining 198 records
resulting in 143 exclusions. The eligibility process started
with 46 articles for the full review. Eleven articles did not
qualify after further review. There were 35 studies
included in the detailed literature review.
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2
0

The most frequent dataset was generalized as patient data
with a frequency of 37%. These studies incorporated a
patient study. This was the most frequent due to the
researcher's access to patient data and patients. The
second most frequent dataset was the use of BRATS
(Brain Tumor Segmentation) at 23%. The anatomical site
most frequently investigated is the brain with 45% of
occurrences. The second is lung at 14% and the third is breast at 11%.

Figure 2. GAN tasks used in papers
Figure 2 shows the frequency of articles by the medical task. The most
common task GANs were involved with was related to tumor segmentation with 43%. Tumor detection and classification were
the second and third with 14% and 11%, respectively. Tumor synthesis and growth prediction individually made up 5% of the
tasks. The remaining tasks individually made up 3% of the tasks investigated.
Figure 3 shows the modality frequency for each article.
Magnetic resonance imaging (MRI) and computed
tomography (CT) were the most used image inputs with
49% and 26%, respectively. Two modalities were tied
for the third, which were multi-modal and
mammograms, individually ranking at 6%.
Conditional GAN (cGAN) was the most frequently
employed technique at 23%. That variant also was used
in 6 different anatomical sites. 46% of the variants used
focused on solving the brain tumor task which is the
most common problem that researchers investigated.
The lung tumor task at 11% was the second most
targeted task. This problem has used four different
approaches to GAN to solve the problem.
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Image comparison was the most used visualization measured at 43%.
Other studies incorporated some

Figure 3. Modalities in papers

type of image comparison and another type of visualization made up
40%. Other models included AUC charts, loss graphs, ROC charts, and specific measures related to the modalities.
DISCUSSION
Generative adversarial network variants

The most prevalent GAN used was the conditional GAN (cGAN). This was used in tumor segmentation with MRIs and
mammograms (B. Yu et al., 2018; Singh et al., 2020), tumor detection with sample tiles (Tavolara et al., 2019), growth
prediction using CTs (A. Liebgott et al., 2019), localization with a 3D-CT (Wei et al., 2020), and diagnosis with whole-slide
tiles (Rana et al., 2020), suggesting that cGANs may be the most effective GAN used for different types of medical tasks with
different types of input modalities. cGANs are used to capture auxiliary information (B. Yu et al., 2018). This variant is broad
in nature and has been used to supplement other models (Teki et al., 2019). While benchmarks generally are used to see how
well the variant performs, in 50% of the articles that used cGAN, none applied a benchmark to compare to other variants (A.
Liebgott et al., 2019; Rana et al., 2020; Wei et al., 2020). Figure 7 presents the other various GAN variants used to solve
medical tasks.
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The variety of variants that have been used demonstrates that researchers and practitioners are trying to find new ways to
achieve the highest performance. Many of the variants used have attempted to combine two or more GAN methods to complete
their studies' objective(s). In fact, in 2018, the only published study used cGAN and five studies in 2019 used cGANs. Aside
from that, only three studies used GAN without any additional variants (Gao & Wang, 2019; Ghassemi et al., 2020; O'Briain
et al., 2020), 77% of the other studies reviewed attempted to use an ensemble GAN technique to achieve higher accuracy. A
substantial amount of work has been conducted to optimize GANs by taking on an ensemble approach. High-quality datasets
are crucial to tackling smaller datasets that plague the tumor-related research problem domain. For example, (C. Ge et al., 2020)
claims that the development of GANs will assist with tackling the commonly encountered problems of insufficiently large brain
tumor datasets and incomplete modality of images.
Dataset size and collection method

Very few studies had extensive datasets in each publication. This is to be expected as the primary purpose of GANs is to try to
augment the data to provide a larger set of data to work with. Four studies did not report dataset size (Elazab et al., 2020; Lee
et al., 2020; N. Xi, 2019; T. E. & K. Saruladha, 2020). The most common dataset size was 200-300 images which accounted
for 28% of the articles. Additionally, 69% of the articles studied held less than 1000 images. Many of the GAN variants were
developed to better understand and use for specific problem domains.
While performance was reported in all studies, there was no common metric to compare across each study. Therefore, it is not
exactly clear whether the size of the study had a significant impact on the findings (Morid et al., 2021). This creates a defined
gap in the research where the understanding of optimal dataset thresholds should be understood, analyzed, and reported to
understand better if dataset size has a significant effect on the performance of deep learning or machine learning approaches
on the replicated datasets created from the GANs. The utility of GAN is not limited by the dataset collection method. 63% of
the studies investigated used public data to develop new variants and study current GANs, while the other 37% of the studies
used patient data from their organizations.
Visualization techniques

A majority (77%) of the reviewed studies visualized the results through image comparison. About 43% of the studies
incorporated just image comparison. The other 34% of the studies incorporated image comparison and a statistical visualization
such as a boxplot detailing further details about the technique used. These visualization techniques should be incorporated into
any GAN study. They can help provide insight into how well the GAN presented a newly created image based on previous data
which will assist with establishing trust in the medical community when considering the utilization of GANs (Borjali et al.,
2020).
Research Agenda:

•
•
•
•
•
•
•
•
•

Further investigation into each anatomical site to understand how each modality reacts to the implementation of GANs.
Tumor detection and segmentation were the most prevalent tumor-related studies. The other problem domains should
be investigated further to see if GANs are as effective in those environments.
Determine if GANs can augment data from different study modalities.
Identify the best performing GAN in the relevant study domain.
Further, investigate the relevance of GANs in radiology information systems.
Determine whether GANs are generalizable to other tasks in the healthcare domain.
Develop a framework to formalize GAN development and allow for generalizability.
Identify whether there is an optimal size of the dataset and its impacts on GAN performance.
Determine which is the most effective visualization for GAN troubleshooting and development.

This study yielded significant results but still had some limitations. Many problem domains regarding image modality and the
anatomical site had limited studies completed. A single researcher classified and identified each article during the systematic
review. The systematic literature review was also limited by only having access to Academic Search Premier, Association for
Computing Machinery, Business Source Premier, IEEE, PubMed, and ScienceDirect. Future research should address the
agenda items posited to begin furthering information system research into GANs.
CONCLUSION

The current state of the literature shows there are still significant contributions to the GAN and tumor-related field. Significant
benefits of using GANs in tumor-related research are the ability to synthesize data, augment data, and create synthetic data to
more successfully train and test models. Given the popularity of GANs and how significant tumor-related research is, in-depth
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research on this topic is quite limited. Understanding the benefits in depth and addressing the items in the research agenda will
enable GANs to be effectively implemented into tumor and health related research.
REFERENCES

1.

2.

3.

4.
5.

6.
7.

8.

9.

10.

11.
12.

13.

14.
15.

16.

17.

18.
19.

A. Liebgott, D. Hindere, K. Armanious, A. Bartler, K. Nikolaou, S. Gatidis, & B. Yangl. (2019). Prediction of FDG
uptake in Lung Tumors from CT Images Using Generative Adversarial Networks. 2019 27th European Signal
Processing Conference (EUSIPCO), 1–5. https://doi.org/10.23919/EUSIPCO.2019.8902935
Aggarwal, A., Mittal, M., & Battineni, G. (2021). Generative adversarial network: An overview of theory and
applications.
International
Journal
of
Information
Management
Data
Insights,
100004.
https://doi.org/10.1016/j.jjimei.2020.100004
B. Yu, L. Zhou, L. Wang, J. Fripp, & P. Bourgeat. (2018). 3D cGAN based cross-modality MR image synthesis for
brain tumor segmentation. 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018), 626–630.
https://doi.org/10.1109/ISBI.2018.8363653
Belanger, F., Watson-Manheim, M. B., & Jordan, D. H. (2002). Aligning IS research and practice: A research agenda
for virtual work. Information Resources Management Journal, 15(3), 23.
Borjali, A., Chen, A. F., Muratoglu, O. K., Morid, M. A., & Varadarajan, K. M. (2020). Deep Learning in Orthopedics:
How Do We Build Trust in the Machine? Healthcare Transformation, heat.2019.0006.
https://doi.org/10.1089/heat.2019.0006
C. Ge, I. Y. Gu, A. S. Jakola, & J. Yang. (2020). Enlarged Training Dataset by Pairwise GANs for Molecular-Based
Brain Tumor Classification. IEEE Access, 8, 22560–22570. https://doi.org/10.1109/ACCESS.2020.2969805
Creswell, A., White, T., Dumoulin, V., Arulkumaran, K., Sengupta, B., & Bharath, A. A. (2018). Generative
Adversarial
Networks:
An
Overview.
IEEE
Signal
Processing
Magazine,
35(1),
53–65.
https://doi.org/10.1109/MSP.2017.2765202
Elazab, A., Wang, C., Gardezi, S. J. S., Bai, H., Hu, Q., Wang, T., Chang, C., & Lei, B. (2020). GP-GAN: Brain tumor
growth prediction using stacked 3D generative adversarial networks from longitudinal MR Images. Neural Networks,
132, 321–332. Academic Search Premier.
Gao, X., & Wang, X. (2019). Deep learning for World Health Organization grades of pancreatic neuroendocrine
tumors on contrast-enhanced magnetic resonance images: A preliminary study. International Journal of Computer
Assisted Radiology and Surgery, 14(11), 1981–1991. https://doi.org/10.1007/s11548-019-02070-5
Ghassemi, N., Shoeibi, A., & Rouhani, M. (2020). Deep neural network with generative adversarial networks pretraining for brain tumor classification based on MR images. Biomedical Signal Processing and Control, 57, 101678.
https://doi.org/10.1016/j.bspc.2019.101678
Goodfellow, I. J., Pouget-Abadie, J., Mirza, M., Xu, B., Warde-Farley, D., Ozair, S., Courville, A., & Bengio, Y.
(2014). Generative Adversarial Networks. ArXiv:1406.2661 [Cs, Stat]. http://arxiv.org/abs/1406.2661
Isola, P., Zhu, J.-Y., Zhou, T., & Efros, A. A. (2017). Image-to-Image Translation with Conditional Adversarial
Networks. 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 5967–5976.
https://doi.org/10.1109/CVPR.2017.632
Kazeminia, S., Baur, C., Kuijper, A., van Ginneken, B., Navab, N., Albarqouni, S., & Mukhopadhyay, A. (2020).
GANs
for
medical
image
analysis.
Artificial
Intelligence
in
Medicine,
109,
101938.
https://doi.org/10.1016/j.artmed.2020.101938
Lee, H., Jo, J., & Lim, H. (2020). Study on Optimal Generative Network for Synthesizing Brain Tumor-Segmented
MR Images. Mathematical Problems in Engineering, 1–12. Academic Search Premier.
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P., Clarke, M., Devereaux, P. J.,
Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of
studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6(7), e1000100.
Morid, M. A., Borjali, A., & Del Fiol, G. (2021). A scoping review of transfer learning research on medical image
analysis
using
ImageNet.
Computers
in
Biology
and
Medicine,
128,
104115.
https://doi.org/10.1016/j.compbiomed.2020.104115
N. Xi. (2019). Semi-supervised Attentive Mutual-info Generative Adversarial Network for Brain Tumor
Segmentation. 2019 International Conference on Image and Vision Computing New Zealand (IVCNZ), 1–7.
https://doi.org/10.1109/IVCNZ48456.2019.8961008
O’Briain, T. B., Yi, K. M., & Bazalova‐Carter, M. (2020). Technical Note: Synthesizing of lung tumors in computed
tomography images. Medical Physics, 47(10), 5070–5076. Academic Search Premier.
Rana, A., Lowe, A., Lithgow, M., Horback, K., Janovitz, T., Da Silva, A., Tsai, H., Shanmugam, V., Bayat, A., &
Shah, P. (2020). Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of

24th Proceedings of the Southern Association for Information Systems Conference, Myrtle Beach, SC, USA March 18th–19th, 2022

5

Behrens and Noteboom

20.

21.

22.

23.

24.
25.

26.

27.

Generative Adversarial Networks in Tumor-Related

Prostate Core Biopsy Images for Tumor Diagnosis. JAMA Network Open, 3(5), e205111.
https://doi.org/10.1001/jamanetworkopen.2020.5111
Singh, V. K., Rashwan, H. A., Romani, S., Akram, F., Pandey, N., Sarker, M. M. K., Saleh, A., Arenas, M., Arquez,
M., Puig, D., & Torrents-Barrena, J. (2020). Breast tumor segmentation and shape classification in mammograms
using generative adversarial and convolutional neural network. Expert Systems with Applications, 139, 112855.
https://doi.org/10.1016/j.eswa.2019.112855
Sorin, V., Barash, Y., Konen, E., & Klang, E. (2020). Creating Artificial Images for Radiology Applications Using
Generative Adversarial Networks (GANs) – A Systematic Review. Academic Radiology, 27(8), 1175–1185.
https://doi.org/10.1016/j.acra.2019.12.024
T. E. & K. Saruladha. (2020). Design of FCSE-GAN for Dissection of Brain Tumour in MRI. 2020 International
Conference on Smart Technologies in Computing, Electrical and Electronics (ICSTCEE), 1–6.
https://doi.org/10.1109/ICSTCEE49637.2020.9276797
Tavolara, T. E., Niazi, M. K. K., Arole, V., Chen, W., Frankel, W., & Gurcan, M. N. (2019). A modular cGAN
classification framework: Application to colorectal tumor detection. Scientific Reports, 9(1), 18969.
https://doi.org/10.1038/s41598-019-55257-w
Teki, S. M., Varma, M. K., & Yadav, A. K. (2019). Brain Tumour Segmentation Using U-net Based Adversarial
Networks. Traitement Du Signal, 36(4), 353–359. Business Source Premier.
Wei, R., Liu, B., Zhou, F., Bai, X., Fu, D., Liang, B., & Wu, Q. (2020). A patient-independent CT intensity matching
method using conditional generative adversarial networks (cGAN) for single x-ray projection-based tumor
localization. Physics in Medicine and Biology, 65(14), 145009. https://doi.org/10.1088/1361-6560/ab8bf2
Xiao, C., Choi, E., & Sun, J. (2018). Opportunities and challenges in developing deep learning models using electronic
health records data: A systematic review. Journal of the American Medical Informatics Association, 25(10), 1419–
1428. https://doi.org/10.1093/jamia/ocy068
Yi, X., Walia, E., & Babyn, P. (2019). Generative Adversarial Network in Medical Imaging: A Review. Medical
Image Analysis, 58, 101552. https://doi.org/10.1016/j.media.2019.101552

24th Proceedings of the Southern Association for Information Systems Conference, Myrtle Beach, SC, USA March 18th–19th, 2022

6

